Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.29
(
-0.04%
)
US TECH 100
26,169.20
(
-0.13%
)
Dow Jones
49,483.95
(
-0.01%
)
Brent Oil
98.18
(
1.50%
)
Bitcoin
78,228.48
(
-0.01%
)
News Focus
News Focus
Post# of 15662
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JohnnyD3

Send PM Follow Ignore
Followers 3
Posts 383
Boards Moderated 0
Alias Born 08/25/2012

JohnnyD3

Re: MDizzle post# 14810

Tuesday, 02/16/2016 10:58:45 AM

Tuesday, February 16, 2016 10:58:45 AM

Post# of 15662
After the 2012 Adcom meeting the FDA admitted they did not realize what a serious debilitating disease it is <sigh> - so the independent IOM and the NIH P2P reports helped them realize.

HEB has a big advantage - ampligen is the only drug to undergo pivotal phase II and phase III FDA trials. Not to mention 18+ years of cost recovery compassionate care treatment.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote